Aptadel Therapeutics
Aptadel Therapeutics is a preclinical-stage biotech company located in Barcelona, Spain. We are developing an RNA-based delivery platform for cancer treatment. The platform is based on Aptamer technologies. Our lead indication is Ewing Sarcoma, a rare variety of bone cancer, affecting children.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Aptadel Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- JA
Jazmine Arévalo
Scientific Project Manager · Science
EmailPhone - AG
Adrian Gabriel Torres
Chief Scientific Officer · Science
EmailPhone - GL
Gisela Lorente
Ó Ñ Á · Other
EmailPhone - NP
Nadia Pons
Chief Operations Officer · Operations
EmailPhone
Showing 4 of 6 verified contacts
Top roles at Aptadel Therapeutics
6 distinct titles indexed · top 6 shown.
- 1acting coo
- 1chief operations officer
- 1chief scientific officer
- 1fundador aptadel therapeutics
- 1scientific project manager
- 1ó ñ á
Sign up to unlock all 6 contacts at Aptadel Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Aptadel Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.